Volatile anesthetic-induced preconditioning

Perfusion (United Kingdom)

Volumn 29, Issue 1, 2014, Pages 10-15

  Swyers, T ^a   Redford, D ^a   Larson, D F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

anesthetics; ischemia; KATP channels; preconditioning; protein kinase C

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; DESFLURANE; HEAT SHOCK PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INHALATION ANESTHETIC AGENT; ISOFLURANE; PROPOFOL; PROTEIN KINASE C; REMIFENTANIL; SEVOFLURANE; SUPEROXIDE DISMUTASE;

BISPECTRAL INDEX; CARDIOPLEGIA; CLINICAL PRACTICE; DRUG CLEARANCE; DRUG HALF LIFE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ANESTHETICS; ISCHEMIA; KATP CHANNELS; PRECONDITIONING; PROTEIN KINASE C;

ANESTHETICS, INHALATION; ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL;

EID: 84890926907     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659113503975     Document Type: Review

References (34)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 ; 74: 1124-1136
2. Hausenloy DJ, Yellon DM Gersh BJ Saperia GM, ed. Waltham, MA.
3. Li YW, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J. 1992 ; 123: 346-353
4. Baxter GF, Goma FM, Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol. 1997 ; 92: 159-167
5. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg. 1998 ; 65: 748-752
6. Cason B, Gamperl A, Slocum R, Kickey R. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology. 1997 ; 87: 1182-1190
7. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology. 1997 ; 86: 699-709
8. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and cardiac preconditioning.Part I. Signalling and cytoprotective mechanisms. Br J Anaesthesia. 2003 ; 91: 551-565
9. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC. Isoflurane mimics ischemic preconditioning via activation of KATP channels. Anesthesiology. 1997 ; 87: 361-370
10. Bland JHL, Lowenstein E. Halothane-induced decrease in experimental myocardial ischemia in the non-failing canine heart. Anesthesiology. 1976 ; 45: 287-293
11. Lochner A, Harper IS, Salie R, Genade S, Coetzee AR. Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion. Anesth Analg. 1994 ; 79: 226-233
12. Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev. 2007 ; 12: 181-188
13. Liu G, Thornton J, Van Winkle D, Stanley A, Olsson R, Downey J. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991 ; 84: 350-356
14. Krieg T, Qin Q, Philipp S, Alexeyev M, Cohen M, Downey J. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol. 2004 ; 287: H2606 - H2611
15. Bolli R, Dawn B, Tang X, et al. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol. 1998 ; 93: 325-338
16. Oldenburg O, Qin Q, Krieg T, et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG and mitoKATP channel opening and leads to cardioprotection. Am J Physiol. 2004 ; 286: H468 - H476
17. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology. 2004 ; 100: 707-721
18. Bernard JM, Wouters PF, Doursout MF, Florence B, Chelly JE, Merin RG. Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology. 1990 ; 72: 659-662
19. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology. 1999 ; 91: 1437-1446
20. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial Katp channels via multiple signaling pathways. Anesthesiology. 2002 ; 97: 4-14
21. O'Rourke B. Myocardial K (ATP) channels in preconditioning. Circ Res. 2000 ; 87: 845-855
22. Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD. Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria. Am J Physiol. 2001 ; 280: H649 - H657
23. Liu Y, Sato T, Seharaseyon J, Szewczyk A, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: viable candidate effectors of ischemic preconditioning. Ann N Y Acad Sci. 1999 ; 874: 27-37
24. Laclau MN, Boudina S, Thambo JB, et al. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol. 2001 ; 33: 947-956
25. Yvon A, Hanouz JL, Haelewyn B, et al. Mechanisms of sevoflurane-induced myocardial preconditioning in isolated human right atria. in vitro. Anesthesiology. 2003 ; 99: 27-33
26. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology. 2000 ; 92: 1400-1407
27. Ludwig LM, Patel HH, Gross GJ, Kersten JR, Pagel PS, Warltier DC. Morphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial KATP channels and opioid receptors. Anesthesiology. 2003 ; 98: 705-711
28. Ambrosio G, Tritto I, Chiariello M. The role of oxygen free radicals in preconditioning. J Mol Cell Cardiol. 1995 ; 27: 1035-1039
29. Van der Linden PJ, Daper A, Trenchant A, De Hert SG. Cardioprotective effects of volatile anesthetics in cardiac surgery. Anesthesiology. 2003 ; 99: 516-517
30. De Hert SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 2002 ; 97: 42-49
31. Guarracino F, Landoni G, Tritapepe L, et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vascular Anesth. 2006 ; 20: 477-483
32. Riess ML, Stowe DF, Warltier DC. Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside?. Am J PhysiolHeart Circ Physiol. 2004 ; 286: H1603 - H1607
33. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg. 2005 ; 100: 1584-1593
34. Law-Koune JD, Raynaud C, Liu N, Dubois C, Romano M, Fischler M. Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia. J Cardiothorac Vascr Anesth. 2006 ; 20: 484-492